The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

DLA Piper LLP (US)

401 B STREET, SUITE 1700, SAN DIEGO, CA 92101-4297, USA
Tel:
Work +1 619 699 2700
Fax:
Fax +1 619 699 2701
Web:
www.dlapiper.com

Christopher Young

Tel:
Work +1 619 699 4748
Email:
Web:
www.dlapiper.com/en/us/people/y/young-christopher-m/
DLA Piper LLP (US)

Work Department

Litigation, Arbitration and Investigations; Product Liability, Mass Torts and Product Stewardship; Class Actions; Intellectual Property and Technology; International Trade, Regulatory and Government Affairs; Cross-Border Litigation; Commercial Contracts Disputes; Life Sciences; Healthcare

Position

Partner

Career

Christopher Young is an experienced trial lawyer and litigator who concentrates his practice in the defense of consumer class action litigation, product liability and mass tort litigation, and pharmaceutical and medical device litigation. His clients include life sciences companies, product manufacturers, food and beverage companies, educational institutions, transportation companies and others.

Christopher represents clients on a local, national and global basis and has extensive experience with the use of various forms of technology to coordinate and support complex mass tort litigation.

Christopher is also a member of DLA Piper's North America Pro Bono Committee and of the firm's Associate Evaluation and Compensation Committee.

Languages

Spanish

Member

Defense Research Institute (DRI); Barrister, Louis M. Welsh Chapter, American Inns of Court

Education

J.D., University of California at Berkeley; B.A., Pomona College


United States: Dispute resolution

Product liability, mass tort and class actions: pharmaceuticals and medical devices - defense

Within: Product liability, mass tort and class actions: pharmaceuticals and medical devices - defense

DLA Piper LLP (US) is headed by Raymond Williams in Philadelphia and Christopher Young in San Diego, and is one of the leading firms for high-profile product liability litigation and mass torts in the medical and pharmaceuticals sectors. Notable highlights include representing Medtronic and Covidien as co-national counsel in the hernia mesh litigation, and defending Pfizer and Wyeth Pharmaceuticals in product liability litigation, in which plaintiffs claim that long-term use of proton pump inhibitors (PPIs) cause various forms of kidney disease. In other work, the highly regarded Loren Brown in New York is acting for Pfizer alongside Boston-based Matthew Holian in an MDL involving claims that anti-coagulant medication Eliquis causes bleeding. Cara Edwards in New York is also recommended. In January 2018, the team welcomed Stephen Matthews and Amy Rubenstein from Porzio, Bromberg & Newman and Schiff Hardin LLP respectively; in February 2018, Matt Nickel and Mike Moore joined from Dentons.

[back to top]


Back to index

Legal Developments by:
DLA Piper LLP (US)

  • Sentencing guidelines for corporate manslaughter

    In February 2010 the Sentencing Guidelines Council (the SGC) issued definitive guidelines to courts on imposing appropriate sentences for corporate manslaughter and health and safety offences causing death. The SGC states that fines imposed on companies found guilty of corporate manslaughter should not fall below £500,000, while fines in respect of health and safety offences that are a significant cause of death should be at least £100,000. Crucially, the SGC declined to provide for a fixed link between the imposed fine and the turnover or profitability of the offending company.

    - DLA Piper UK LLP

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to